Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 19Unknown 12Recruiting 6Terminated 3Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Motor Activity 3Colorectal Neoplasms 2Vomiting 1Urologic Neoplasms 1Urinary Incontinence 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pain, Postoperative 1Ovarian Neoplasms 1Osteolysis 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Nausea 1Multiple Myeloma 1Lung Neoplasms 1Liver Diseases 1Liver Cirrhosis 1Jaw Cysts 1Hematologic Neoplasms 1Breast Neoplasms 1

Interventions

Paclitaxel 62Letrozole 55Fulvestrant 55Trastuzumab 50palbociclib 41pembrolizumab 37Cyclophosphamide 37Carboplatin 37Anastrozole 37pertuzumab 35exemestane 25Tamoxifen 24Capecitabine 24ribociclib 23abemaciclib 23Radiotherapy 21Docetaxel 21olaparib 20Doxorubicin 20Magnetic Resonance Spectroscopy 19trastuzumab deruxtecan 17Surveys and Questionnaires 17durvalumab 16Epirubicin 16Specimen Handling 14Exercise 14130-nm albumin-bound paclitaxel 14Taxes 13Alpelisib 13Goserelin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Breast Neoplasms × Control Groups × Clear all
NCT02991677 2024-08-06

Exercise Effect on Chemotherapy-Induced Neuropathic Pain

Baltimore VA Medical Center

Phase NA Active not recruiting
60 enrolled
BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Motor Activity, Ovarian Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡